📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice. (2013)

First Author: Haagensen EJ

Attributed to: MRC Contribution to a CR-UK and EPSRC Cancer Imaging Initiative funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0081763

PubMed Identifier: 24339963

Publication URI: http://europepmc.org/abstract/MED/24339963

Type: Journal Article/Review

Volume: 8

Parent Publication: PloS one

Issue: 12

ISSN: 1932-6203